TherapeuticsMD® For Her. For Life. ■ ■ Building the Premier Women's Health Company 1Q 2021 Earnings May 6, 2021 Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we," "our," or the "Company") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, exp ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-00100 THERAPEUTICSMD, INC. (Exact name of Registrant as specified in its Charter) Nevada 87-0233535 (State or ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Rob Finizio - Chief Executive Officer James D'Arecca - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Mitchell Krassan - Chief Strategy & Performance Officer Conference Call Participants Dana Flanders - Guggenheim Partners Douglas Tsao - H.C. Wainwright Operator Good morning, ladies and gentlemen. Thank you for joining us for T ...

TherapeuticsMD® 1 For Her. For Life. Building the Premier Women's Health Company Our focus for 2021 is on executing our plans to accelerate revenue growth March 9, 2021 Forward-Looking Statements 2 This presentation by TherapeuticsMD, Inc. (referred to as "we," "our," or the "Company") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that add ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ________________________ Commission File Number 001-00100 TherapeuticsMD, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other ...

TherapeuticsMD® For Her. For Life. ■ Building the Premier Women's Health Company 4Q 2020 Earnings March 2, 2021 Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we," "our," or the "Company") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, exp ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q4 2020 Earnings Conference Call March 2, 2021 8:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer James D'Arecca - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Mitchell Krassan - Chief Strategy & Performance Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Annabel Samimy - Stifel Douglas Tsao - H.C. Wainwright Operator Good morning, ladies and gentlemen. Thank ...

TherapeuticsMD® For Her. For Life. 3Q 2020 Earnings November 9, 2020 FOR INVESTOR PRESENTATION PURPOSES ONLY. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we," "our," or "the Company") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expec ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Nichol Ochsner – Vice President of Investor Relations Robert Finizio – Chief Executive Officer James D’Arecca – Chief Financial Officer Dawn Halkuff – Chief Commercial Officer Mitchell Krassan – Chief Strategy and Performance Officer Conference Call Participants Nick Rubino – Stifel Carvey Leung – Cantor Fitzgerald Stacy Ku – Cowen and Company Douglas Tsao – H.C. Wainwright Dana Flanders – Gu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ___________ Commission File No. 001-00100 THERAPEUTICSMD, INC. (Exact Name of Registrant as Specified in Its Charter) Nevada 87-0233535 (State ...